Skip to main content

Advertisement

Fig. 2 | Thrombosis Journal

Fig. 2

From: The CD31 molecule: a possible neuroprotective agent in acute ischemic stroke?

Fig. 2

Relation between CD31+ cells and early patient improvement. Example of an immunostained specimen with almost no stained nucleated cells (a) and an example with many CD31+ stained cells (b). In this example, there is almost no "staining-negative" cell visible. c Boxplot analysis with regression line in red, showing the relationship between amount of CD31+-cells (0 = no cells, 1 = sporadic, 2 = few, 3 = some, 4 = many) and early patient improvement (represented by ΔNIHSS)

Back to article page